Topic · Blood groups and transfusion
Most cited papers in Blood groups and transfusion
What are the most cited papers in Blood groups and transfusion?
The most cited paper in Blood groups and transfusion is "Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group" (Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer et al., 2008), with 2,707 citations. Next come "Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA Replication" (2,653) and "Genomic atlas of the human plasma proteome" (2,496).
Showing 50 of 100 papers. Every paper with more than 678 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer et al. · Blood | 12 Nov 2008 | 2,707 |
| 2 | Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA Replication Howard G. Gratzner · Science | 29 Oct 1982 | 2,653 |
| 3 | Genomic atlas of the human plasma proteome Benjamin B. Sun et al. · Nature | 29 May 2018 | 2,496 |
| 4 | SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES Mikael Jondal, G. Holm, Hans Wigzell · The Journal of Experimental Medicine | Aug 1972 | 2,445 |
| 5 | Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma Chenguang Shen et al. · JAMA | 27 Mar 2020 | 2,425 |
| 6 | Sickle-cell disease David C. Rees, Thomas Neil Williams, Mark T. Gladwin · The Lancet | Dec 2010 | 2,398 |
| 7 | Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia Samuel Charache, Michael L. Terrin, Richard D. Moore et al. · New England Journal of Medicine | 18 May 1995 | 2,361 |
| 8 | International consensus report on the investigation and management of primary immune thrombocytopenia Drew Provan et al. · Blood | 21 Oct 2009 | 2,283 |
| 9 | A dot-immunobinding assay for monoclonal and other antibodies Richard B. Hawkes, Evelyn Niday, Julian A. Gordon · Analytical Biochemistry | 1982 | 2,192 |
| 10 | Role of CD47 as a Marker of Self on Red Blood Cells Per‐Arne Oldenborg, Alex Zheleznyak, Yifu Fang et al. · Science | 16 Jun 2000 | 1,979 |
| 11 | SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION Pekka Saikku, Kari J. Mattila, Markku S. Nieminen et al. · The Lancet | Oct 1988 | 1,974 |
| 12 | Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura G. A. Rock, Kenneth H. Shumak, Noel A. Buskard et al. · New England Journal of Medicine | 8 Aug 1991 | 1,940 |
| 13 | Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis Colin James Barnstable · Cell | May 1978 | 1,936 |
| 14 | The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia Cindy E. Neunert, Wendy Lim, Mark Andrew Crowther et al. · Blood | 16 Feb 2011 | 1,869 |
| 15 | HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantation Ole Olerup, Henrik Zetterquist · Tissue Antigens | May 1992 | 1,822 |
| 16 | von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome Miha Furlan, Rodolfo Robles, Miriam Galbusera et al. · New England Journal of Medicine | 26 Nov 1998 | 1,676 |
| 17 | HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD Paul A. Imbach, Vincenzo D’Apuzzo, Andreas Hirt et al. · The Lancet | Jun 1981 | 1,672 |
| 18 | Application of a Microtechnique to Viral Serological Investigations John L. Sever · The Journal of Immunology | Mar 1962 | 1,629 |
| 19 | Management of Sickle Cell Disease Barbara P. Yawn, George R. Buchanan, Araba Afenyi‐Annan et al. · JAMA | 9 Sep 2014 | 1,608 |
| 20 | Pain in Sickle Cell Disease Orah S. Platt, Bruce D. Thorington, Donald J. Brambilla et al. · New England Journal of Medicine | 4 Jul 1991 | 1,559 |
| 21 | Quantitative Determination of Serum Immunoglobulins in Antibody-Agar Plates John L. Fahey, Eugene M. McKelvey · The Journal of Immunology | 1965 | 1,535 |
| 22 | Common Variable Immunodeficiency: Clinical and Immunological Features of 248 Patients Charlotte Cunningham‐Rundles, Carol Bodian · Clinical Immunology | Jul 1999 | 1,525 |
| 23 | Beta-thalassemia Renzo Galanello, Raffaella Origa · Orphanet Journal of Rare Diseases | 21 May 2010 | 1,490 |
| 24 | International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology Kim Solez et al. · Kidney International | Aug 1993 | 1,463 |
| 25 | Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies Marina Botto, Chiara Dell' Agnola, Anne E. Bygrave et al. · Nature Genetics | May 1998 | 1,437 |
| 26 | The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease William John Astle et al. · Cell | Nov 2016 | 1,429 |
| 27 | Antigen-antibody crossed electrophoresis C.‐B. Laurell · Analytical Biochemistry | Feb 1965 | 1,423 |
| 28 | Sickle cell disease Gregory James Kato, Frédéric B. Piel, Clarice D. Reid et al. · Nature Reviews Disease Primers | 14 Mar 2018 | 1,422 |
| 29 | American Society of Hematology 2019 guidelines for immune thrombocytopenia Cindy E. Neunert, Deirdra R. Terrell, Donald M. Arnold et al. · Blood Advances | 3 Dec 2019 | 1,411 |
| 30 | AGAMMAGLOBULINEMIA Ogden C. Bruton · PEDIATRICS | Jun 1952 | 1,385 |
| 31 | BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR J. Evan Sadler · Annual Review of Biochemistry | Jun 1998 | 1,378 |
| 32 | The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States* Howard L. Corwin, Andrew Gettinger, Ronald G. Pearl et al. · Critical Care Medicine | 2004 | 1,357 |
| 33 | Immune Thrombocytopenic Purpura Douglas B. Cines, Victor S. Blanchette · New England Journal of Medicine | 28 Mar 2002 | 1,351 |
| 34 | Noninvasive Diagnosis by Doppler Ultrasonography of Fetal Anemia Due to Maternal Red-Cell Alloimmunization Giancarlo Mari, Russell L. Deter, Robert L. Carpenter et al. · New England Journal of Medicine | 6 Jan 2000 | 1,349 |
| 35 | Atypical Hemolytic–Uremic Syndrome Marina Noris, Giuseppe Remuzzi · New England Journal of Medicine | 21 Oct 2009 | 1,346 |
| 36 | The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Peter Hillmen, Neal S. Young, Jörg E. A. Schubert et al. · New England Journal of Medicine | 21 Sep 2006 | 1,305 |
| 37 | Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease Elliott P. Vichinsky, Lynne Neumayr, Ann Noonan Earles et al. · New England Journal of Medicine | 22 Jun 2000 | 1,250 |
| 38 | Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation Michael L. Cleary, Stephen Dale Smith, Jeffrey L. Sklar · Cell | Oct 1986 | 1,237 |
| 39 | Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion Jeffrey L. Carson, Simon J. Stanworth, Nareg H. Roubinian et al. · Cochrane Database of Systematic Reviews | 12 Oct 2016 | 1,227 |
| 40 | Population Estimates of Sickle Cell Disease in the U.S. Kathryn Louise Hassell · American Journal of Preventive Medicine | 21 Mar 2010 | 1,227 |
| 41 | Molecular genetic basis of the histo-blood group ABO system Fumi-ichiro Yamamoto, Henrik Clausen, Thayer White et al. · Nature | May 1990 | 1,206 |
| 42 | Pathogenesis and Treatment of Sickle Cell Disease H. Franklin Bunn · New England Journal of Medicine | 11 Sep 1997 | 1,162 |
| 43 | A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery Dean A. Fergusson, Paul C. Hébert, C. David Mazer et al. · New England Journal of Medicine | 14 May 2008 | 1,156 |
| 44 | Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor J. Evan Sadler et al. · Journal of Thrombosis and Haemostasis | 14 Sep 2006 | 1,154 |
| 45 | Updated international consensus report on the investigation and management of primary immune thrombocytopenia Drew Provan et al. · Blood Advances | 26 Nov 2019 | 1,151 |
| 46 | Clinical Practice Guidelines From the AABB Jeffrey L. Carson, Gordon Henry Guyatt, Nancy M. Heddle et al. · JAMA | 12 Oct 2016 | 1,129 |
| 47 | Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo Si Lok et al. · Nature | Jun 1994 | 1,122 |
| 48 | Characterization of a human B lymphocyte-specific antigen. Philip Stashenko, Lee Marshall Nadler, Russell Hardy et al. · The Journal of Immunology | Oct 1980 | 1,088 |
| 49 | Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin Kenneth Kaushansky, Si Lok, Richard D. Holly et al. · Nature | Jun 1994 | 1,069 |
| 50 | IgG Placental Transfer in Healthy and Pathological Pregnancies Patrícia Palmeira, Camila Quinello, Ana Lúcia Silveira-Lessa et al. · Clinical and Developmental Immunology | 3 Oct 2011 | 1,058 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.